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Abstract
Background: Although the consequences of the COVID-19 pandemic on emotional health are
evident, little is known about its impact on patients with obsessive-compulsive disorder (OCD).
Methods: One hundred and twenty-seven patients with OCD who attended a specialist OCD
Clinic in Barcelona, Spain, were assessed by phone from April 27 to May 25, 2020, during the
early phase of the pandemic, using the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS) and
a structured interview that collected clinical and sociodemographic information. Results were
compared with those for 237 healthy controls from the same geographic area who completed an
online survey.
Results: Although 65.3% of the patients with OCD described a worsening of their symptoms,
only 31.4% had Y-BOCS scores that increased >25%. The risk of getting infected by SARS-CoV2
was reported as a new obsession by 44.8%, but this only became the main obsessive concern in
approximately 10% of the patients. Suicide-related thoughts were more frequent among the
OCD cohort than among healthy controls. The presence of prepandemic depression, higher
Y-BOCS scores, contamination/washing symptoms, and lower perceived social support all
predicted a significantly increased risk of OCD worsening.
Conclusions:Most patients with OCD appear to be capable of coping with the emotional stress
of the COVID-19 outbreak and its consequences during the initial phase of the pandemic.
Nevertheless, the current crisis constitutes a risk factor for a significant worsening of symptoms
and suicidal ideation. Action is needed to ensure effective and individualized follow-up care for
patients with OCD in the COVID-19 era.
Introduction
On January 30, 2020, theWorld Health Organization declared the global COVID-19 outbreak to
be an international public health emergency, and on March 11, declared that it had become a
pandemic. As such, 2020 has seen social distancing and the adoption of strict hand and
respiratory hygiene elevated as key strategies to control the spread of infection. There have been
constant reminders for us all to wash our hands frequently and to avoid physical contact with
other people and specific surfaces, behaviors that resemble those commonly exhibited by patients
with obsessive–compulsive disorder (OCD) with contamination obsessions and washing com-
pulsions.
Faced with the health, social, and economic consequences of the pandemic, almost 40% of the
general population and more than 70% of health workers refer psychological distress, insomnia,
anxiety, and depressive symptoms [1–4]. However, there is little data on how the current COVID-
19 outbreak is affecting patients with OCD, a population that is more likely to have concerns about
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northern Italy describe a clinical worsening in more than a third of
the subjects [7], andmajor vulnerability in those with contamination
symptoms and in remission before the pandemic [8].
Beyond the fears related to the risk of contagion, potentially
powerful stressors have arisen from the dramatic social and eco-
nomic changes. These include home confinement, limited freedom,
economic uncertainty, and difficulties accessing mental health
services. For a stress-sensitive condition such as OCD, for which
60% of patients report stressful life events as a trigger for symptoms
[9–11], the current milieu constitutes a period of serious vulnera-
bility. At the same time, there are some important moderating
features. Some patients may have had less need to face their fears
thanks to the need for confinement during the pandemic. More-
over, there has been an acceptance and social normalization of
some OCD behaviors, such as continuous hand washing or glove
and sanitizer use, which were previously classified as pathological.
Clearly, there are many unknowns about how patients with OCD
have faced the pandemic and whether their disease protects against
or worsens the negative psychological effects of the COVID-19
pandemic.
In this study, we aimed to evaluate the impact of the COVID-19
pandemic on a sample of patients withOCD at the initial stage of the
health crisis, assessing not only changes in OCD severity, but also in
pre-existing conditions, newly developed conditions, treatment, use
of mental health resources, development of obsessive fears of SARS-
CoV-2 contamination, and use of emotional regulation and stress
coping strategies. Our hypothesis was that potential clinical and
social predictive factors, both risk- and protection-related, including
among others baseline OCD severity, specific symptom profiles,
comorbid conditions, perceived social support or exposure to
COVID-19 related news, could be established for changes in OCD
status during the COVID-19 pandemic, allowing prevention strate-
gies to be developed that focus on the most vulnerable patients.
Method
Participants and procedure
We invited adult outpatients who had been attending the specialist
OCD Clinical and Research Unit of the Department of Psychiatry,
Hospital de Bellvitge, Barcelona, Spain, for at least one year before
March 2020 to participate in the study. Extensive clinical and
sociodemographic information were available for these patients
from before the pandemic. At an initial assessment, two indepen-
dent psychiatrists with extensive clinical experience in OCD had
checked that all participants fulfilled the diagnostic criteria for
OCD according to the Structured Clinical Interview for The Diag-
nostic and Statistical Manual of Mental Disorders, Fifth Edition
(DSM-5), Clinician Version [12]. After this first assessment,
patients received pharmacological treatment and/or cognitive-
behavioral therapy (CBT) according to international guidelines
[13] and were asked to provide written informed consent to be
included in a naturalistic follow-up cohort to study long-term
prognosis of OCD. We excluded patients with psychoactive sub-
stance abuse/dependence (current or in the previous 6 months),
psychotic disorders, intellectual disability, severe organic or neu-
rological pathology (except tic disorders), or autism spectrum
disorders at baseline from the cohort. The naturalistic cohort study
involved quarterly visits in which obsessive and depressive symp-
toms were assessed using specific psychometric tools, with treat-
ment adjusted according to the responses of each patient. For this
study, we contacted those patients who had completed at least one
year of treatment in our center before March 2020 and who had
been on stable doses of medication for at least 3 months. This
especially restrictive inclusion criterion was adopted to ensure that
changes on OCD symptoms that could be detected at the initial
stages of the pandemic were not affected by confounding factors
such as recent changes on treatment.
Assessments were performed from April 27 to May 25, 2020.
The requirement for strict confinement imposed by the Spanish
government necessitated that we cancelled face-to-face hospital
visits for psychiatric patients from March 15, 2020, in all but
extreme urgency. As such, patients with OCD received outpatient
follow-up by telephone. This included interviews and clinical
assessments by their regular psychiatrist to determine the need
for treatment adjustment. It was during these telephone consulta-
tions that eligible patients were given the option to participate in the
study. After informing patients about the study’s purposes and
characteristics, oral consent was obtained and recorded in their
medical history. Those who agreed to participate then underwent a
structured interview specifically designed for the study. This lasted
20–25 min and was also conducted by their regular psychiatrist.
Participants from the general populationwere recruited through
social networks, using a snowball method. Requirements for inclu-
sion in the controls group were age >18 years old, no history of
psychological or psychopharmacological treatment, no prior diag-
nosis of a mental disorder, and living in Catalonia throughout the
COVID-19 pandemic. An adapted version of the structured inter-
view delivered to the OCD group (excluding OCD-related ques-
tions) was sent as an online survey via social networks to
participants in the control group, who provided written informed
consent to participate in the study. Snowball sampling has the
drawback, like all nonrandom sampling, of not guaranteeing the
representativeness of the population. To reduce this risk, an initial
selection of individuals was designed to guarantee access to subjects
of all cultural and socioeconomic levels of the population, request-
ing the participation of cleaning kitchen and maintenance person-
nel of the university and hospital, health workers of all levels and
blood bank donors, and the contacts of all of them. The rate of a
number of unemployed subjects (16%) coinciding with the unem-
ployed rate in Spain at the initial stages of the pandemic, suggests
that the group of healthy controls can be considered representative
of the socioeconomic status of the general population.
The study was approved by the Ethics Committee of the Hos-
pital de Bellvitge and was performed in accordance with the prin-
ciples established by the declaration of Helsinki, as revised in 1989.
Measures
The structured interview that we designed specifically for this study
assessed seven thematic blocks:
1. Sociodemographic data: age, gender, civil status, educational
level, employment situation, changes in employment, and/or
income during the pandemic.
2. Social context: type of family coexistence (living alone, with
birth family, own family, or friends), perceived family and
social support (yes/no on whether you perceive you have
(a) someone to confidently talk, (b) someone to provide com-
pany, and (c) environment offers help and support), leaving
home pattern during the pandemic, time spent listening/read-
ing to news about the pandemic and perceived changes on
family atmosphere and harmony during the pandemic
(no change/better/worse).
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3. Contact with COVID-19: confirmed or suspected COVID-19,
hospitalization related to COVID-19, and admission to inten-
sive care unit due to COVID-19 in the subject/family/close
friends; COVID-19 death of a family member or close friend.
4. Medical conditions: chronic medical conditions (including
respiratory diseases, obesity, diabetes, hypertension, kidney
or liver failure, immunodeficiencies, cancer, and/or trans-
plants); use of tobacco, alcohol, and drugs before and during
the pandemic, categorically (yes/no) and continuously
assessed (number of daily tobacco or cannabis cigarettes, daily
standard drink units or weekly episodes of cocaine, heroin, or
psychoactive drugs use).
5. Emotional regulation and stress coping strategies: worries
about getting COVID-19; worries about family members get-
ting COVID-19; concerns about home isolation and loss of
routines, difficulties contacting mental health services (for the
patients withOCD), separation from loved ones and economic
consequences of the pandemic were assessed through 0–4
Likert scales with 0 = no or very little, 1 = little, 2 = some, 3
= quite, and 4 = a lot. Use of stress coping strategies included
questions (yes/no) on physical exercise practice, mindfulness/
meditation practice, yoga, relaxation techniques, using of
online social/family networking, establishing a daily routine
and hobbies, and distracting activities.
6. General psychiatric data: perceived changes in eating patterns
(no change and increased/decreased appetite) and sleeping
patterns (no change, early/middle/late insomnia, nightmares,
and need medication to sleep), depression and anxiety levels
since March 14, 2020, according to a visual analog scale (VAS;
0 = no anxiety/no depressive symptoms and 10 = severely
anxious/depressed); suicidal ideation according to the Hamil-
ton Depression Rating Scale (HDRS; item on suicide)
[14]. Development of new psychiatric symptoms was assessed
by a battery of questions adapted from the Structured Clinical
Interview for DSM-5-Clinician version [12] including ques-
tions on depression, manic episodes, panic attacks, generalized
anxiety, specific phobias, social phobia, psychotic symptoms,
and impulse control disorders, such as compulsive buying,
compulsive Internet use, and pathological gambling.
7. OCD-related questions (OCDgroup only): changes needed for
the treatment of OCD during the pandemic, need for urgent
care or psychiatric hospitalization during the pandemic,
changes in OCD severity according to the clinician-
administered Yale–Brown Obsessive–Compulsive Scale
(Y-BOCS)[15], changes in OCD symptomatology according
to the Y-BOCS symptom checklist (previous and newly devel-
oped symptoms during the pandemic with a specific question
on fears of contamination by SARS-CoV2). The Y-BOCS rates
obsessions and compulsions separately on five dimensions:
time spent, degree of interference, distress, resistance and
perceived control over symptoms. The 10 Y-BOCS items are
each scored on a 4-point scale from 0 (none) to 4 (extreme).
Total score ranges from 0 to 40 (0–7: subclinical; 8–15: mild;
16–23: moderate; 24–31: severe; and 33–40: extreme OCD).
Clinical data were available for patients in the OCD group just
before the pandemic outbreak in March 2020. This included scores
on the clinician-administeredHDRS, Y-BOCS, and Y-BOCS symp-
tom checklist (last assessment between December 14, 2019 and
March 14, 2020); age at OCD onset (defined as the moment when
obsessive symptoms reached a clinically significant level); andOCD
treatment, including type, dose, and duration of pharmacological
treatment and/or previous or ongoing CBT.
Statistical analysis
Descriptive statistics were calculated and are reported. Independent
sample Student t-tests and Pearson Chi-squared tests were carried
out to explore the differences in sociodemographic and clinical
variables between the OCD and control groups. Paired sample
Student t-tests were also performed to assess potential changes in
OCD severity (obsessions, compulsions, and total Y-BOCS scores)
from before to after the COVID-19 outbreak.
To explore the potential predictors of changes in OCD during
the pandemic, we first performed bivariate analysis to assess the
association of each sociodemographic, pandemic-related, and clin-
ical variable with changes on the Y-BOCS scores from before the
pandemic to assessment in April or May 2020. In a second step, we
conducted a generalized linear regression analysis with changes on
Y-BOCS scores as the dependent variable and those variables
significantly associated with these changes in the bivariate analysis
as independent variables (prepandemic HDRS score, prepandemic
Y-BOCS score, contamination or cleaning symptoms and perceived
social support). Significance was set at p < 0.05 and all analyses were
carried out using IBM SPSS Version 24 for Windows.
Results
Samples characteristics
We included 364 subjects in the study (127 OCD patients and
237 healthy controls). Six more OCD patients who fulfilled inclu-
sion criteria could not be contacted and three patients declined to
participate in the study because they preferred not to discuss their
symptoms over the phone (response rate 93.3%). Since the healthy
control group was recruited through the snowball method, we lack
information about how many subjects received the interview and
refused to complete it.
Before the pandemic, 33 (25.9%) patients with OCD fulfilled
criteria for remission, showing residual obsessions and compul-
sions that did not interfere with their everyday lives (Y-BOCS
scores <12) [16]. The sociodemographic characteristics of the two
groups are described in Table 1. Significant differences between the
OCD and control groups were detected for educational level,
working status, family structure, changes in economic income,
perceived support, and effect on family life during the pandemic.
Patients with OCD had completed fewer years of education (12.7
2.8 vs. 14.6 2.6) and developed paid work activity less frequently
than healthy subjects, with 54% of them being unemployed or
receiving a disability pension. These results are consistent with
those from other cohorts of OCD patients and with recent studies
indicating that OCD is associated with lower educational attain-
ment and marked difficulties to participate in the labor market
[17, 18]. Healthy controls reported more perceived emotional
support, more changes in their economic income, and less wors-
ening of family life during confinement than OCD patients.
Direct contact with SARS-CoV2 infection
No significant differences were detected between the OCD and
control groups in personal or family history of confirmed or
suspected SARS-CoV2 infection, as well as hospital and intensive
care unit admissions. The same was true for the number of family
members or friends who died from COVID-19. However, healthy
controls more frequently reported having close friends diagnosed
with COVID-19 and/or needed to be admitted to hospital or
intensive care units (Supplementary Table S1).
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Psychopathology during the pandemic
Psychopathology arose from different domains in each group dur-
ing the pandemic, as described in Table 2. Compared with controls,
the OCD group scored higher on perceived levels of anxiety and
depression, had more frequent suicide-related thoughts, and more
often experienced changes in perceived eating and sleeping pat-
terns. The appearance of depressive symptoms that subjectively
affected the individual’s functionality was more frequent in the
OCD group, while the control group described more pathological
behaviors related to impulse control, including pathological
gambling, compulsive internet use, or compulsive buying. Healthy
subjects also consumed more alcohol before the pandemic than the
OCD group and tended to increase consumption significantly
during the confinement. No significant differences were detected
for tobacco or other drugs use.
Emotional regulation and stress coping strategies
Patients with OCD were more concerned than healthy controls
about the risks to themselves or their families of being infected by
Table 1. Social and clinical characteristics of OCD patients and healthy controls.
Variables OCD (n = 127) Control (n = 236) t or Χ2 p
95% Interval confidence
Lower/upper
Age, years (mean  SD) 42.0  11.3 40.8  12.3 0.9a 0.3 1.32 3.86
Years of education, years (mean  SD) 12.7  2.8 14.6  2.6 6.3a <0.001 2.4 1.31
Age at OCD onset, years (mean  SD) 17.5  6.2
Gender (male/female) 59/68 100/136 0.5 0.4
Civil status, n, % Single 55 (43.3%) 83 (35.1%) 5.5 0.1
Married 59 (46.4%) 133 (56.3%
Divorced/widowed 13 (10.2%) 20 (8.4%)
Working status, n, % Paid employment 44 (34.6%) 69 (29.2%) 73.9 <0.001
Self-employment 10 (7.8%) 82 (34.7%)
Students 4 (3.1%) 0 (0%)
Unemployed 16 (12.5%) 38 (16.1%)
Pensioners 53 (41.7%) 1 (0.4%)
Living status, n, % Alone 17 (13.3%) 17 (7.2%) 10.3 0.01
Birth family 40 (31.4%) 50 (21.1%)
Own family 67 (52.7%) 161(68.2%)
With friends 3 (2.3%) 8 (3.3%)
Living with other mentally ill subjects, yes, n, % 14 (11.0%) 13 (5.5%) 3.6 0.05
Living with dependents (children, parents), yes, n, % 45 (35.4%) 75 (31.7%) 0.4 0.4
Perceived support sources,
yes, n, %
Someone to confidently talk 103 (81.1%) 226(95.7%) 20.9 <0.001
Someone to provide company 102 (80.3%) 221(93.6%) 14.9 <0.001
Environment offers help and support 109 (85.8%) 210(88.9%) 0.7 0.3
Income, n, % No change 100 (78.7%) 136(57.6%) 25.0 <0.001
20% reduction 0 (0%) 30 (12.7%)
20–50% reduction 14 (11.0%) 29 (12.2%)
>50% reduction 10 (7.8%) 28 (11.8%)
Increase 3 (2.3%) 13 (5.5%)
Exists during confinement, n, % Never 32 (25.1%) 0 (0%) 201.9 <0.001
1–2/week 62 (48.8%) 13 (5.5%)
3–6/week 4 (3.1%) 103(43.6%)
Daily 33 (25.9%) 120(50.8%)
Family harmony n, % No change 60 (47.2%) 113(47.8%) 10.0 0.007
Better 32 (25.1%) 88 (37.2%)
Worse 35 (27.5%) 36 (15.2%)
Abbreviation: OCD, OCD, obsessive–compulsive disorder.
aResults by t-test; all others are by χ2.
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Table 2. Psychopatology during the pandemic among OCD patients and healthy controls.
Variables OCD (n = 127) Controls (n = 237) t or Χ2 p
95% Interval confidence
Lower/upper
Anxiety (VAS) 6.0  2.3 3.3  2.6 4.9 <0.001 2.0 3.1
Depression (VAS) 5.4  2.5 2.2  2.3 0.9 <0.001 2.7 3.7
Fear of getting COVID-19 2.8  1.3 2.2  0.8 5.1 <0.001 0.37 0.83
Fear of family members getting COVID-19 3.7  1.1 3.1  1.0 5.1 <0.001 0.38 0.85
Worried about confinement 2.8  1.1 2.3  1.0 4.3 <0.001 0.27 0.74
Impossibility of family contact 3.1  1.1 2.9  1.0 2.1 0.03 0.01 0.48
Economic consequences 2.9  1.1 2.8  1.1 1.1 0.2 0.11 0.39
Daily hours listening/reading COVID-19 related news 1.6  1.6 0.8  1.0 6.2 <0.001 0.6 1.1
Drug consumption, n, % Tobacco 28(22.0%) 56(23.7%) 0.1 0.7
Alcohol 5 (3.9%) 77(32.6%) 38.6 <0.001
Other drugs Cannabis 2 (1.5%) 9 (3.8%) 3.4 0.3
Cocaine 1 (0.7%) 1 (0.4%)
Other drugs 0 (0%) 0 (0%)
Increase in drug consumption,
n, %
Tobacco 15(11.8%) 18 (7.6%) 1.7 0.1
Alcohol 5 (3.9%) 23 (9.7%) 3.8 0.04
Other drugs 0 (0%) 3 (1.2%) 1.6 0.2
Suicide, n, % Absent 90(70.8%) 231 (97.8%) 56.1 <0.001
Feels life is not worth living 25(19.6%) 4 (1.6%)
Wishes he/she were dead 5 (3.9%) 1 (0.4%)
Ideas or gestures of suicide 7 (5.5%) 1 (0.4%)
Attempts at suicide 0 (0%) 0 (0%)
Eating pattern, n % No change 48(37.7%) 101 (42.7%) 13.0 0.04
Increase appetite 50(39.3%) 101 (42.7%)
Decreased appetite 29(22.8%) 35(14.8%)
Sleep pattern, n, % No change 59(46.4%) 110 (46.6%) 13.2 0.02
Early insomnia 33(25.9%) 63(26.6%)
Middle insomnia 24(18.8%) 46(19.4%)
Early wake-up 3 (2.3%) 16 (6.7%)
Nightmares 3 (2.3%) 2 (0.8%)
Need medication to sleep 4 (3.1%) 0 (0%)
Coping strategies,a n, % Physical exercise 61(48.0%) 179 (75.8%) 27.8 <0.001
Meditation 23(18.1%) 53(22.4%) 0.9 0.3
Yoga 12 (9.4%) 59 (25%) 12.5 <0.001
Muscular relaxation 32(25.1%) 53(22.4%) 0.3 0.4
Distracting activities 62(48.8%) 115 (48.7%) 0.003 0.9
Time routine 74(58.2%) 164 (69.4%) 4.3 0.03
Online or real conversations 105 (82.6%) 199 (84.3%) 0.1 0.7
New psychiatric difficulties during
confinement, n, %
Depression 41(32.2%) 9 (3.8%) 61.2 <0.001
Panic attacks 1 (0.7%) 4 (1.6%)
Excessive worrying (GAD) 5 (3.9%) 11 (4.6%)
Specific phobias 0 (0%) 1 (0.4%)
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SARS-CoV2 and the loss of their daily routines due to the pan-
demic. Both groups had similar concerns about the economic
consequences of the crisis and loss of family contact. Regarding
coping strategies, patients with OCD tended to engage in less
physical exercise and yoga than healthy controls and reported that
it was more difficult for them to establish a daily routine. Both
groups used online or face-to-face conversations as themain coping
strategies for coping with emotional distress (Table 2).
Changes on OCD symptomatology
A statistically significant increase in Y-BOCS scores was detected in
the OCD sample during the first months of the pandemic (t =8.3,
p < 0.001), with an average 2.7-point increase in Y-BOCS scores. It
represents a 15.1% increase from baseline scores, a percentage that
can be considered of little clinical relevance (clinical changes of at
least 25% are required for example as an operational criteria for
partial response [16]). No significant differences were detected
when comparing patients who met the pre-pandemic criteria for
remission and those who experienced time-consuming and life-
interfering symptoms before the COVID-19 outbreak (t = 0.4,
p = 0.6).
Although 83 patients (65.3%) described a worsening of their
symptoms, only 40 (31.4%) showed an increase of >25% from
their pre-pandemic Y-BOCS scores, indicating at least moderate
clinical relevant repercussion (Table 3). In this group, an average
increase on Y-BOCS scores of 7.0 points 2.21 (range: 4–12) was
detected, with Y-BOCS scores increasing from mean scores of
18.1  4.1 at prepandemic assessment to 25.1  5.4 after the
COVID outbreak, which indicates moving from suffering a mod-
erate OCD to a severe form of the disorder. It was notable that
20 patients (15.7%) described a significant improvement in their
obsessions and compulsions, experiencing a mean decrease in
their Y-BOCS scores of 11.1%. Although 57 patients (44.8%)
reported new obsessions and compulsions specifically related to
the risk of contamination by SARS-CoV-2, this only became the
main obsessive concern for 12 (9.4%). Obsessive fears about
COVID-19 occurred more frequently among those who reported
contamination/washing symptoms before the pandemic than
those with other symptom dimensions. Indeed, 78.9% reporting
this fear as a new symptom already suffered from contamination
obsessions and compulsions (increasing to 83.3% for those in
whom this fear became the main obsession). Pharmacological
treatment needed to be changed in the first months of the pan-
demic for 32 (25.1%) patients, with all but two of these receiving
increased selective serotonin reuptake inhibitor or clomipramine
doses (n = 16), increased antipsychotic doses (n = 3), or the
addition or increase of benzodiazepine doses.
Table 2. Continued
Variables OCD (n = 127) Controls (n = 237) t or Χ2 p
95% Interval confidence
Lower/upper
Eating disorders 0 (0%) 2 (0.8%)
Pathological gambling 0 (0%) 2 (0.8%)
Compulsive buying or web use 4 (3.1%) 7 (2.9%)
Compulsive pornography use 1 (0.7%) 2 (0.8%)
Abbreviations: GAD, generalized anxiety disorder; OCD, obsessive-compulsive disorder; VAS visual analog scale.
aResults not adjusted for other variables.
Table 3. Changes in OCD symptomatology and related conditions.
HDRS baseline
(m, SD, range) 10.8  5.3 (2–22)
Y-BOCS baseline Obsessions 9.0  3.1 (3–17)
Compulsions 8.8  3.1 (2–17)
Total 17.8  6.2 (6–34)
Y-BOCS confinement Obsessions 10.4  3.7 (3–17)
Compulsions 10.0  3.9 (2–17)




Change on Y-BOCS score
(n,%)
Improvement
(n = 20, 15.7%)
11.1  5.0
(3.5–16.4)
mean  SD (range) No change
(n = 24, 18.8 %)
Worsening (n = 83, 65.3%) 25.6  16.1
(4.5–87.5)































SSRI or clomipramine +
antipsychotic
56 (44.0%)
6 P. Alonso et al.
Linear regression analysis showed that the following signifi-
cantly predicted a worsening of OCD symptomatology during the
first months of the COVID-19 outbreak (R2 = 0.30; F = 10.2):
prepandemic HDRS (p < 0.001) and Y-BOCS scores (p = 0.006);
the presence of contamination/washing obsessions and compul-
sions (p = 0.002); and lower perceived social support (p = 0.04)
(Table 4).
Discussion
In the present study, patients with OCD experienced a moderate
worsening of their symptomatology during the first months of the
pandemic. Increases in obsessions and compulsions were especially
relevant for those with more severe forms of OCD, associated
depressive symptoms, contamination or washing obsessions and
rituals, and less perceived emotional support before the pandemic.
It was notable that patients with OCD were at increased risk of
suicidal thoughts and/or acts and changes on perceived eating and
sleeping patterns, and that they had higher perceived levels of
anxiety and depression, compared to healthy controls. These last
ones, on their hand, exhibited more pathological behaviors related
to impulse control including pathological gambling, compulsive
internet use, or compulsive buying. These results coincide with the
risk indicated by the experts, on some vulnerable subjects, of
developing addictive disorders as a consequence of the inappropri-
ate use of online activities such as gambling, shopping, video
gaming or social media use, as dysfunctional strategies to reduce
emotional distress or improve mood [19].
The percentage of patients withOCD in our sample who showed
an increase in symptoms (65.3%) was similar to that described after
online surveys by Jelinek et al. [20] in a sample of 394 OCD patients
from Germany (72%) and by Wheaton et al. in a group of 252 self-
identified adults with OCD from the United States (76.2%) [21]. In
all three cases, this percentage was significantly higher than the
35.8% reported by Benatti et al. [7] in northern Italy. However, the
Italian study lacked a psychometric assessment and reported only
on “global clinical worsening,” a concept that might better corre-
sponds to the 31.4% of our patients who presented a worsening of
Y-BOCS scores >25%, a value associated with a significant func-
tional impairment. It is interesting that the net Y-BOCS increases
between our study and that of Davide et al. [8] are comparable,
implying similar outcomes for OCD in countries that have similar
experiences of the pandemic.
It is also remarkable that 15% of our patients described a
significant improvement in symptoms during the pandemic and
that another 20% reported that they remained stable. These results
are in the same line as those described in a recent study of three
Dutch psychiatric cohorts, including a sample of 130OCDpatients,
which describes that patients with more severe and chronic forms
of mental illness showed a reduction in the severity of their symp-
toms during the first weeks of the pandemic [22]. Although we
cannot exclude that home isolation led to some indirect avoidance
of obsession-inducing situations, our results suggest that many
patients with OCD could adapt to the great personal and social
changes forced on them by the pandemic. In fact, resilience in the
face of potential traumamay bemore common than is often believe
[23]. This ability to cope with difficulties is mediated by multiples
determinants, with perceived social support being among the most
important protective factors against posttraumatic stress both in
general [24] and in front of the COVID-19 pandemic [25]. Patients
with OCD in our sample perceived less emotional support than the
healthy controls, and this variable was associated with a higher risk
of symptom deterioration during the pandemic. This stresses the
importance of promoting all methods of social support, including
video calls with friends and family. Crucially, access to self-help
groups and community resources was drastically reduced during
the first months of the pandemic in Spain. Perhaps this decision
should be reassessed to reduce feelings of loneliness and improve
social support in psychiatric patients.
Among the patients with OCD, those with symptoms related to
contamination/cleaning were most vulnerable to clinical deterio-
ration. In this group, 60% reported developing new obsessions
related to the fear of infection by the SARS-CoV-2 virus, with this
becoming the main concern for 13.3%. By contrast, this concern
was significantly less common for patients with other clinical pre-
sentations. This issue constitutes a therapeutic challenge in the
context of the current pandemic because contamination obsessions
and washing compulsions tend to respond especially well to expo-
sure response prevention [26]. At present, CBT must be used with
caution because of the potential for increased risk of contagion by
the SARS-CoV-2 virus [27]. It is critical that we develop guidelines
for exposure and response prevention therapy that allow clinicians
to conduct exposure therapy responsibly, with special attention to
local COVID-19 risk [28]. However, while the pandemic is not
controlled, other therapeutic approaches may bemore appropriate,
including imaginal exposure, danger ideation reduction therapy,
behavioral activation, and activity scheduling [27]. Activity sched-
uling, in particular, may be especially relevant given our finding
that patients with OCD have more difficulties than the general
population in maintaining a healthy and regular daily routine
during quarantine and home isolation.
Although none of the patients in our sample attempted suicide
during the first weeks of the pandemic, 5.5% described active
suicidal thoughts and 23% had passive suicidal ideation. These
percentages were clearly higher than those in the general popula-
tion, highlighting a need for careful assessment of suicide risk in
patients with OCD during the COVID-19 pandemic [27]. Given
that face-to-face visits have been drastically reduced, it is essential
to ensure close follow-up of OCD patients through telemedicine
resources, something that it is not easy in elderly cohorts, or in those
with either lower educational levels or difficulties in accessing
technological resources [29]. Ensuring safe access to urgent psy-
chiatric care is also essential for patients with OCD, not least
because they may have fears of approaching hospitals due to the
fear of contagion.
One in four patients in our study required medication adjust-
ments during the first months of the pandemic. In the study by
Benatti et al. [7] this was necessary for a 35.7% of their sample and
Table 3. Continued
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increased to 70.5% in the subgroup that experienced a global
worsening of OCD. These therapeutic needs must be taken into
account despite the complex health situation that the pandemic
entails. As with psychiatric services across the world, we have had to
modify our practice to guarantee proper care and support to our
OCD patients. Therapeutic gaps have been filled by improving the
ease of telephone or email contact between therapists and patients,
introducing periodic phone conferencing with patients, and deliv-
ering internet-based CBT. Nevertheless, we must consider that
some patients may find it difficult to follow remote therapies,
especially those of advanced age, with fewer economic resources,
or with less technological skill, and may therefore disengage from
treatment. More than ever, individually tailored treatments are
crucial [30].
The current study presents several limitations. The OCD group
attended a specialist OCD clinic in a tertiary hospital and may not
reflect patients with OCD in the general population, either in terms
of severity or access to specific treatments. Nevertheless, our sample
included patients with both mild and severe forms of the disorder,
with a quarter of the patients meeting the criteria for remission
prior to the pandemic. This also applies to the control groupwho, in
addition to the limitations derived from its obtaining by the snow-
ball system, were chosen through social networks and completed an
online interview, limiting access to those who use this technology.
In this sense, OCD patients were interviewed by telephone while
healthy subjects answered the same questions through an online
questionnaire. Although the formulation of the questions was
identical in both versions, it cannot be ruled out that this method-
ological difference might influence our results. Nevertheless, the
clinical assessment of OCD patients by a specialist through tele-
phone interview is one of the strengths of our study, at a time when
most published results from clinical populations are obtained only
by online interviews. Data were collected in a cross-sectional
assessment and only cover the period to May 2020. It is possible
that patients with OCD adapted better in the early phases of
confinement when government control measures were quite clear
and restrictive, but they may have more difficulties managing later
phases of de-confinement when the margin for personal responsi-
bility is much greater. Prospective data are being acquired in this
same sample to resolve this concern and assess the long-term
impact of COVID-19 in the OCD group. The development of
obsessive fear of COVID-19 contamination in healthy subjects
was not explored due to the difficulty in differentiating them from
normal fear of contagion in an online interview. In this sense,
whether the current pandemic will prove to be a turning point that
increases the global risk of OCD is still unknown.
Our results suggest that most patients with OCD have been
able to cope adequately with the emotional, social, and economic
sequelae associated with the COVID-19 outbreak, at least in the
early stages of the pandemic. However, the current crisis has
constituted a risk for significant worsening, including the develop-
ment of depressive and suicidal symptoms, for one in three patients.
Actions must be taken to guarantee continuous follow-up and
access to adequate and individualized treatment for patients with
OCD while the COVID-19 pandemic is ongoing.
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